[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
October 22/29, 2003

NIH: Plan to Speed Biomedical Payoffs

JAMA. 2003;290(16):2115-2116. doi:10.1001/jama.290.16.2115

The National Institutes of Health (NIH) is "turbo-charging" with a 5-year, $2 billion plan to speed biological discoveries into blockbuster treatments. Designed to leverage leaps in biotechnology, the ambitious strategy aims to reveal the most fundamental workings of the body by encouraging and rewarding high-risk research. A vast network of community physicians is then envisioned to quickly test emerging therapies.

"Some say these initiatives are bold, maybe too bold," said Francis Collins, MD, PhD, director of the National Human Genome Research Institute. "Fifteen years ago they said the same thing about the Human Genome Project."